GO:0032991 | protein-containing complex | 29.96% (77/257) | 1.28 | 0.0 | 0.0 |
GO:0046907 | intracellular transport | 12.06% (31/257) | 1.8 | 0.0 | 2e-06 |
GO:0098796 | membrane protein complex | 8.95% (23/257) | 2.2 | 0.0 | 3e-06 |
GO:0051649 | establishment of localization in cell | 12.06% (31/257) | 1.57 | 0.0 | 5.8e-05 |
GO:0043933 | protein-containing complex organization | 11.67% (30/257) | 1.54 | 0.0 | 0.000119 |
GO:0005515 | protein binding | 53.31% (137/257) | 0.49 | 0.0 | 0.000187 |
GO:0022406 | membrane docking | 2.72% (7/257) | 3.87 | 1e-06 | 0.00023 |
GO:0051641 | cellular localization | 14.4% (37/257) | 1.29 | 1e-06 | 0.000247 |
GO:0006886 | intracellular protein transport | 7.78% (20/257) | 1.88 | 1e-06 | 0.000261 |
GO:0031985 | Golgi cisterna | 2.72% (7/257) | 3.79 | 1e-06 | 0.000266 |
GO:0065003 | protein-containing complex assembly | 10.12% (26/257) | 1.54 | 1e-06 | 0.000406 |
GO:0044877 | protein-containing complex binding | 8.56% (22/257) | 1.69 | 2e-06 | 0.000478 |
GO:0071840 | cellular component organization or biogenesis | 29.18% (75/257) | 0.75 | 2e-06 | 0.000525 |
GO:0016043 | cellular component organization | 27.63% (71/257) | 0.76 | 3e-06 | 0.000727 |
GO:0031201 | SNARE complex | 2.33% (6/257) | 3.9 | 3e-06 | 0.000746 |
GO:0006906 | vesicle fusion | 2.72% (7/257) | 3.41 | 5e-06 | 0.000915 |
GO:0080090 | regulation of primary metabolic process | 26.46% (68/257) | 0.77 | 4e-06 | 0.000932 |
GO:0051223 | regulation of protein transport | 4.28% (11/257) | 2.46 | 7e-06 | 0.001035 |
GO:0140056 | organelle localization by membrane tethering | 2.33% (6/257) | 3.73 | 6e-06 | 0.001079 |
GO:0045184 | establishment of protein localization | 8.95% (23/257) | 1.53 | 6e-06 | 0.001099 |
GO:0090174 | organelle membrane fusion | 2.72% (7/257) | 3.31 | 7e-06 | 0.001107 |
GO:0031323 | regulation of cellular metabolic process | 27.24% (70/257) | 0.74 | 6e-06 | 0.001154 |
GO:0016050 | vesicle organization | 4.28% (11/257) | 2.39 | 1e-05 | 0.00144 |
GO:0019222 | regulation of metabolic process | 30.35% (78/257) | 0.66 | 1.2e-05 | 0.001589 |
GO:0031324 | negative regulation of cellular metabolic process | 13.23% (34/257) | 1.15 | 1.2e-05 | 0.001615 |
GO:0048284 | organelle fusion | 3.5% (9/257) | 2.7 | 1.2e-05 | 0.001617 |
GO:0022607 | cellular component assembly | 13.62% (35/257) | 1.1 | 1.7e-05 | 0.001904 |
GO:0005795 | Golgi stack | 1.95% (5/257) | 3.99 | 1.6e-05 | 0.001916 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 10.12% (26/257) | 1.33 | 1.7e-05 | 0.001954 |
GO:0060255 | regulation of macromolecule metabolic process | 26.07% (67/257) | 0.72 | 1.6e-05 | 0.001977 |
GO:0070201 | regulation of establishment of protein localization | 4.28% (11/257) | 2.27 | 2.1e-05 | 0.002196 |
GO:0009892 | negative regulation of metabolic process | 15.95% (41/257) | 0.99 | 2.1e-05 | 0.002227 |
GO:0061025 | membrane fusion | 2.72% (7/257) | 3.04 | 2.5e-05 | 0.00243 |
GO:0015031 | protein transport | 8.17% (21/257) | 1.49 | 2.4e-05 | 0.002444 |
GO:0030008 | TRAPP complex | 1.17% (3/257) | 5.51 | 3.3e-05 | 0.003109 |
GO:0030307 | positive regulation of cell growth | 3.5% (9/257) | 2.48 | 3.9e-05 | 0.00364 |
GO:0000398 | mRNA splicing, via spliceosome | 3.11% (8/257) | 2.66 | 4.5e-05 | 0.003884 |
GO:0050708 | regulation of protein secretion | 2.33% (6/257) | 3.25 | 4.3e-05 | 0.003889 |
GO:0050714 | positive regulation of protein secretion | 1.95% (5/257) | 3.66 | 4.8e-05 | 0.003914 |
GO:0006903 | vesicle targeting | 1.17% (3/257) | 5.37 | 4.5e-05 | 0.003918 |
GO:0140534 | endoplasmic reticulum protein-containing complex | 2.72% (7/257) | 2.89 | 5e-05 | 0.003978 |
GO:0005681 | spliceosomal complex | 3.89% (10/257) | 2.28 | 4.8e-05 | 0.003997 |
GO:0010605 | negative regulation of macromolecule metabolic process | 14.4% (37/257) | 0.98 | 5.6e-05 | 0.004324 |
GO:0016192 | vesicle-mediated transport | 7.39% (19/257) | 1.49 | 5.7e-05 | 0.004355 |
GO:1902494 | catalytic complex | 10.89% (28/257) | 1.16 | 6.3e-05 | 0.004544 |
GO:0060341 | regulation of cellular localization | 5.84% (15/257) | 1.72 | 6.2e-05 | 0.004576 |
GO:0098978 | glutamatergic synapse | 3.11% (8/257) | 2.58 | 6.5e-05 | 0.004598 |
GO:0043005 | neuron projection | 5.06% (13/257) | 1.87 | 6.9e-05 | 0.004768 |
GO:0031491 | nucleosome binding | 1.95% (5/257) | 3.5 | 8.2e-05 | 0.005579 |
GO:0071705 | nitrogen compound transport | 10.89% (28/257) | 1.14 | 8.5e-05 | 0.005702 |
GO:0070727 | cellular macromolecule localization | 10.51% (27/257) | 1.14 | 0.000105 | 0.006901 |
GO:0033108 | mitochondrial respiratory chain complex assembly | 1.95% (5/257) | 3.38 | 0.000123 | 0.006978 |
GO:0060090 | molecular adaptor activity | 3.5% (9/257) | 2.29 | 0.000109 | 0.007005 |
GO:0051222 | positive regulation of protein transport | 2.72% (7/257) | 2.68 | 0.000122 | 0.007035 |
GO:0051171 | regulation of nitrogen compound metabolic process | 23.35% (60/257) | 0.68 | 0.000114 | 0.007054 |
GO:0045446 | endothelial cell differentiation | 1.17% (3/257) | 4.93 | 0.000121 | 0.007064 |
GO:0003682 | chromatin binding | 5.45% (14/257) | 1.7 | 0.000127 | 0.007075 |
GO:0048278 | vesicle docking | 1.56% (4/257) | 4.0 | 0.000113 | 0.007123 |
GO:0008104 | protein localization | 9.73% (25/257) | 1.19 | 0.00012 | 0.007182 |
GO:0005829 | cytosol | 22.96% (59/257) | 0.69 | 0.000119 | 0.007239 |
GO:0010608 | post-transcriptional regulation of gene expression | 6.23% (16/257) | 1.56 | 0.000134 | 0.007325 |
GO:0045927 | positive regulation of growth | 4.28% (11/257) | 1.97 | 0.000138 | 0.007429 |
GO:0098791 | Golgi apparatus subcompartment | 6.23% (16/257) | 1.55 | 0.000145 | 0.007698 |
GO:0032880 | regulation of protein localization | 5.06% (13/257) | 1.75 | 0.000156 | 0.007916 |
GO:0043197 | dendritic spine | 1.56% (4/257) | 3.89 | 0.000153 | 0.007968 |
GO:0010468 | regulation of gene expression | 21.01% (54/257) | 0.71 | 0.000156 | 0.007992 |
GO:0071702 | organic substance transport | 12.06% (31/257) | 1.02 | 0.000163 | 0.008108 |
GO:0010556 | regulation of macromolecule biosynthetic process | 18.29% (47/257) | 0.78 | 0.000166 | 0.008151 |
GO:0030674 | protein-macromolecule adaptor activity | 3.11% (8/257) | 2.38 | 0.000173 | 0.008359 |
GO:0008380 | RNA splicing | 3.89% (10/257) | 2.05 | 0.000177 | 0.008426 |
GO:0016604 | nuclear body | 5.45% (14/257) | 1.65 | 0.000181 | 0.008527 |
GO:0044309 | neuron spine | 1.56% (4/257) | 3.82 | 0.000184 | 0.008543 |
GO:1904951 | positive regulation of establishment of protein localization | 2.72% (7/257) | 2.58 | 0.000188 | 0.008599 |
GO:0050794 | regulation of cellular process | 39.69% (102/257) | 0.44 | 0.000191 | 0.00864 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 3.11% (8/257) | 2.35 | 0.000199 | 0.008878 |
GO:0036090 | cleavage furrow ingression | 1.17% (3/257) | 4.66 | 0.000213 | 0.009009 |
GO:0043025 | neuronal cell body | 3.11% (8/257) | 2.34 | 0.000205 | 0.009013 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 12.06% (31/257) | 0.99 | 0.000208 | 0.009022 |
GO:1903532 | positive regulation of secretion by cell | 2.33% (6/257) | 2.83 | 0.000212 | 0.009061 |
GO:0051253 | negative regulation of RNA metabolic process | 8.56% (22/257) | 1.22 | 0.000221 | 0.009238 |
GO:0065004 | protein-DNA complex assembly | 2.33% (6/257) | 2.81 | 0.00023 | 0.009261 |
GO:0051047 | positive regulation of secretion | 2.33% (6/257) | 2.81 | 0.00023 | 0.009261 |
GO:0051128 | regulation of cellular component organization | 11.67% (30/257) | 1.01 | 0.000225 | 0.009295 |
GO:0000375 | RNA splicing, via transesterification reactions | 3.11% (8/257) | 2.31 | 0.000236 | 0.009374 |
GO:1904799 | regulation of neuron remodeling | 1.17% (3/257) | 4.59 | 0.000252 | 0.009779 |
GO:1904801 | positive regulation of neuron remodeling | 1.17% (3/257) | 4.59 | 0.000252 | 0.009779 |
GO:0015774 | polysaccharide transport | 0.78% (2/257) | 6.25 | 0.000256 | 0.009833 |
GO:0005484 | SNAP receptor activity | 1.56% (4/257) | 3.69 | 0.000261 | 0.009896 |
GO:0032588 | trans-Golgi network membrane | 1.95% (5/257) | 3.13 | 0.000281 | 0.010562 |
GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding | 1.17% (3/257) | 4.51 | 0.000295 | 0.010941 |
GO:0061024 | membrane organization | 5.06% (13/257) | 1.65 | 0.000314 | 0.011508 |
GO:0090304 | nucleic acid metabolic process | 14.79% (38/257) | 0.84 | 0.000328 | 0.011901 |
GO:0099072 | regulation of postsynaptic membrane neurotransmitter receptor levels | 1.56% (4/257) | 3.6 | 0.000331 | 0.011905 |
GO:0031492 | nucleosomal DNA binding | 1.17% (3/257) | 4.44 | 0.000342 | 0.012162 |
GO:0006139 | nucleobase-containing compound metabolic process | 17.12% (44/257) | 0.76 | 0.000355 | 0.012498 |
GO:0140513 | nuclear protein-containing complex | 8.56% (22/257) | 1.17 | 0.00037 | 0.012875 |
GO:0051123 | RNA polymerase II preinitiation complex assembly | 1.17% (3/257) | 4.37 | 0.000394 | 0.013442 |
GO:0061484 | hematopoietic stem cell homeostasis | 1.17% (3/257) | 4.37 | 0.000394 | 0.013442 |
GO:0000785 | chromatin | 4.28% (11/257) | 1.78 | 0.000415 | 0.014006 |
GO:0060576 | intestinal epithelial cell development | 0.78% (2/257) | 5.93 | 0.000425 | 0.014196 |
GO:0033617 | mitochondrial cytochrome c oxidase assembly | 1.17% (3/257) | 4.31 | 0.000451 | 0.014222 |
GO:0097212 | lysosomal membrane organization | 1.17% (3/257) | 4.31 | 0.000451 | 0.014222 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 14.01% (36/257) | 0.85 | 0.000441 | 0.014285 |
GO:1903829 | positive regulation of protein localization | 3.11% (8/257) | 2.18 | 0.00044 | 0.014403 |
GO:0031326 | regulation of cellular biosynthetic process | 19.84% (51/257) | 0.68 | 0.000437 | 0.014459 |
GO:0051252 | regulation of RNA metabolic process | 16.73% (43/257) | 0.76 | 0.000451 | 0.014483 |
GO:0097110 | scaffold protein binding | 1.17% (3/257) | 4.25 | 0.000513 | 0.015587 |
GO:0014042 | positive regulation of neuron maturation | 1.17% (3/257) | 4.25 | 0.000513 | 0.015587 |
GO:0048523 | negative regulation of cellular process | 18.29% (47/257) | 0.71 | 0.000504 | 0.015719 |
GO:0009889 | regulation of biosynthetic process | 20.23% (52/257) | 0.66 | 0.000512 | 0.015844 |
GO:0044297 | cell body | 3.11% (8/257) | 2.14 | 0.000533 | 0.01605 |
GO:0001046 | core promoter sequence-specific DNA binding | 1.56% (4/257) | 3.39 | 0.000586 | 0.016731 |
GO:0035145 | exon-exon junction complex | 1.17% (3/257) | 4.19 | 0.000581 | 0.01686 |
GO:0140220 | pathogen-containing vacuole | 1.17% (3/257) | 4.19 | 0.000581 | 0.01686 |
GO:0033036 | macromolecule localization | 10.51% (27/257) | 0.99 | 0.000586 | 0.016867 |
GO:0090407 | organophosphate biosynthetic process | 4.67% (12/257) | 1.63 | 0.000576 | 0.017028 |
GO:0000139 | Golgi membrane | 4.67% (12/257) | 1.63 | 0.000576 | 0.017028 |
GO:0070897 | transcription preinitiation complex assembly | 1.17% (3/257) | 4.13 | 0.000653 | 0.01759 |
GO:0008535 | respiratory chain complex IV assembly | 1.17% (3/257) | 4.13 | 0.000653 | 0.01759 |
GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity | 0.78% (2/257) | 5.66 | 0.000635 | 0.017668 |
GO:0009330 | DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) complex | 0.78% (2/257) | 5.66 | 0.000635 | 0.017668 |
GO:0016048 | detection of temperature stimulus | 0.78% (2/257) | 5.66 | 0.000635 | 0.017668 |
GO:0019887 | protein kinase regulator activity | 2.33% (6/257) | 2.53 | 0.00065 | 0.017808 |
GO:0005575 | cellular_component | 70.82% (182/257) | 0.21 | 0.000645 | 0.017818 |
GO:0030855 | epithelial cell differentiation | 2.33% (6/257) | 2.52 | 0.000672 | 0.017821 |
GO:0000307 | cyclin-dependent protein kinase holoenzyme complex | 1.95% (5/257) | 2.86 | 0.000668 | 0.017858 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 17.51% (45/257) | 0.7 | 0.000736 | 0.019213 |
GO:0014041 | regulation of neuron maturation | 1.17% (3/257) | 4.08 | 0.000731 | 0.019228 |
GO:0000791 | euchromatin | 1.56% (4/257) | 3.29 | 0.000755 | 0.019547 |
GO:0016021 | integral component of membrane | 14.01% (36/257) | 0.8 | 0.000767 | 0.019708 |
GO:0019207 | kinase regulator activity | 2.33% (6/257) | 2.48 | 0.00079 | 0.020147 |
GO:0006325 | chromatin organization | 3.89% (10/257) | 1.77 | 0.00081 | 0.020331 |
GO:0061695 | transferase complex, transferring phosphorus-containing groups | 3.11% (8/257) | 2.02 | 0.000895 | 0.020335 |
GO:0006355 | regulation of DNA-templated transcription | 15.18% (39/257) | 0.75 | 0.00089 | 0.020354 |
GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex | 0.78% (2/257) | 5.44 | 0.000885 | 0.020382 |
GO:0032011 | ARF protein signal transduction | 0.78% (2/257) | 5.44 | 0.000885 | 0.020382 |
GO:0055108 | Golgi to transport vesicle transport | 0.78% (2/257) | 5.44 | 0.000885 | 0.020382 |
GO:1902824 | positive regulation of late endosome to lysosome transport | 0.78% (2/257) | 5.44 | 0.000885 | 0.020382 |
GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport | 0.78% (2/257) | 5.44 | 0.000885 | 0.020382 |
GO:1903337 | positive regulation of vacuolar transport | 0.78% (2/257) | 5.44 | 0.000885 | 0.020382 |
GO:1990583 | phospholipase D activator activity | 0.78% (2/257) | 5.44 | 0.000885 | 0.020382 |
GO:0002066 | columnar/cuboidal epithelial cell development | 0.78% (2/257) | 5.44 | 0.000885 | 0.020382 |
GO:0045727 | positive regulation of translation | 2.72% (7/257) | 2.23 | 0.000807 | 0.020422 |
GO:0048193 | Golgi vesicle transport | 3.5% (9/257) | 1.89 | 0.000832 | 0.02074 |
GO:0032984 | protein-containing complex disassembly | 2.33% (6/257) | 2.42 | 0.000952 | 0.02092 |
GO:2001141 | regulation of RNA biosynthetic process | 15.18% (39/257) | 0.75 | 0.000948 | 0.020973 |
GO:1902679 | negative regulation of RNA biosynthetic process | 7.39% (19/257) | 1.17 | 0.000942 | 0.020975 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 7.39% (19/257) | 1.17 | 0.000942 | 0.020975 |
GO:0098797 | plasma membrane protein complex | 1.95% (5/257) | 2.78 | 0.000859 | 0.021102 |
GO:1903506 | regulation of nucleic acid-templated transcription | 15.18% (39/257) | 0.75 | 0.000938 | 0.021173 |
GO:0010604 | positive regulation of macromolecule metabolic process | 14.4% (37/257) | 0.78 | 0.000858 | 0.02124 |
GO:0006397 | mRNA processing | 4.28% (11/257) | 1.65 | 0.000872 | 0.021259 |
GO:0006417 | regulation of translation | 4.67% (12/257) | 1.54 | 0.001003 | 0.02189 |
GO:0006401 | RNA catabolic process | 2.72% (7/257) | 2.17 | 0.001012 | 0.021946 |
GO:0048522 | positive regulation of cellular process | 21.01% (54/257) | 0.6 | 0.001021 | 0.021993 |
GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity | 1.56% (4/257) | 3.16 | 0.001069 | 0.022882 |
GO:1903431 | positive regulation of cell maturation | 1.17% (3/257) | 3.88 | 0.001102 | 0.023444 |
GO:0051246 | regulation of protein metabolic process | 10.51% (27/257) | 0.92 | 0.001145 | 0.023756 |
GO:0014069 | postsynaptic density | 2.33% (6/257) | 2.37 | 0.001138 | 0.023761 |
GO:0099572 | postsynaptic specialization | 2.33% (6/257) | 2.37 | 0.001138 | 0.023761 |
GO:0006357 | regulation of transcription by RNA polymerase II | 7.78% (20/257) | 1.11 | 0.001127 | 0.023829 |
GO:0045956 | positive regulation of calcium ion-dependent exocytosis | 0.78% (2/257) | 5.25 | 0.001175 | 0.02407 |
GO:0060292 | long-term synaptic depression | 0.78% (2/257) | 5.25 | 0.001175 | 0.02407 |
GO:0008375 | acetylglucosaminyltransferase activity | 1.17% (3/257) | 3.83 | 0.00121 | 0.024496 |
GO:0051254 | positive regulation of RNA metabolic process | 10.12% (26/257) | 0.94 | 0.001204 | 0.024519 |
GO:0051179 | localization | 20.23% (52/257) | 0.6 | 0.00137 | 0.027569 |
GO:0019003 | GDP binding | 1.56% (4/257) | 3.06 | 0.001392 | 0.027845 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 5.45% (14/257) | 1.35 | 0.001434 | 0.028515 |
GO:0098794 | postsynapse | 1.95% (5/257) | 2.59 | 0.001512 | 0.02971 |
GO:0030130 | clathrin coat of trans-Golgi network vesicle | 0.78% (2/257) | 5.08 | 0.001504 | 0.029719 |
GO:0030150 | protein import into mitochondrial matrix | 1.17% (3/257) | 3.7 | 0.001574 | 0.030561 |
GO:0032388 | positive regulation of intracellular transport | 1.95% (5/257) | 2.58 | 0.001566 | 0.030585 |
GO:0006402 | mRNA catabolic process | 2.33% (6/257) | 2.28 | 0.001593 | 0.03076 |
GO:0005814 | centriole | 1.17% (3/257) | 3.66 | 0.001709 | 0.032241 |
GO:1903429 | regulation of cell maturation | 1.17% (3/257) | 3.66 | 0.001709 | 0.032241 |
GO:2000469 | negative regulation of peroxidase activity | 1.17% (3/257) | 3.66 | 0.001709 | 0.032241 |
GO:0016197 | endosomal transport | 2.72% (7/257) | 2.04 | 0.001723 | 0.032334 |
GO:0034250 | positive regulation of cellular amide metabolic process | 2.72% (7/257) | 2.04 | 0.001686 | 0.032361 |
GO:0034248 | regulation of cellular amide metabolic process | 4.67% (12/257) | 1.45 | 0.00175 | 0.03265 |
GO:0005751 | mitochondrial respiratory chain complex IV | 0.78% (2/257) | 4.93 | 0.001872 | 0.032727 |
GO:0098974 | postsynaptic actin cytoskeleton organization | 0.78% (2/257) | 4.93 | 0.001872 | 0.032727 |
GO:0099188 | postsynaptic cytoskeleton organization | 0.78% (2/257) | 4.93 | 0.001872 | 0.032727 |
GO:1902822 | regulation of late endosome to lysosome transport | 0.78% (2/257) | 4.93 | 0.001872 | 0.032727 |
GO:0015939 | pantothenate metabolic process | 0.78% (2/257) | 4.93 | 0.001872 | 0.032727 |
GO:0061951 | establishment of protein localization to plasma membrane | 1.56% (4/257) | 2.96 | 0.001779 | 0.033002 |
GO:0008156 | negative regulation of DNA replication | 1.17% (3/257) | 3.62 | 0.00185 | 0.033407 |
GO:0009048 | dosage compensation by inactivation of X chromosome | 1.17% (3/257) | 3.62 | 0.00185 | 0.033407 |
GO:0010222 | stem vascular tissue pattern formation | 1.17% (3/257) | 3.62 | 0.00185 | 0.033407 |
GO:1905615 | positive regulation of developmental vegetative growth | 1.17% (3/257) | 3.62 | 0.00185 | 0.033407 |
GO:2000468 | regulation of peroxidase activity | 1.17% (3/257) | 3.62 | 0.00185 | 0.033407 |
GO:0051234 | establishment of localization | 17.9% (46/257) | 0.63 | 0.001867 | 0.033531 |
GO:0140296 | general transcription initiation factor binding | 1.56% (4/257) | 2.93 | 0.001952 | 0.033779 |
GO:1901371 | regulation of leaf morphogenesis | 1.56% (4/257) | 2.93 | 0.001952 | 0.033779 |
GO:0071824 | protein-DNA complex subunit organization | 2.33% (6/257) | 2.22 | 0.001966 | 0.033842 |
GO:0071806 | protein transmembrane transport | 1.95% (5/257) | 2.5 | 0.001982 | 0.033941 |
GO:0042393 | histone binding | 2.72% (7/257) | 2.0 | 0.002003 | 0.034129 |
GO:0005669 | transcription factor TFIID complex | 1.17% (3/257) | 3.55 | 0.002155 | 0.03564 |
GO:0016251 | RNA polymerase II general transcription initiation factor activity | 1.17% (3/257) | 3.55 | 0.002155 | 0.03564 |
GO:1902554 | serine/threonine protein kinase complex | 1.95% (5/257) | 2.48 | 0.002114 | 0.035658 |
GO:1900618 | regulation of shoot system morphogenesis | 1.56% (4/257) | 2.89 | 0.002137 | 0.035682 |
GO:0032506 | cytokinetic process | 1.56% (4/257) | 2.89 | 0.002137 | 0.035682 |
GO:0045892 | negative regulation of DNA-templated transcription | 7.0% (18/257) | 1.1 | 0.002113 | 0.03583 |
GO:0043248 | proteasome assembly | 1.17% (3/257) | 3.51 | 0.002319 | 0.036364 |
GO:0099024 | plasma membrane invagination | 1.17% (3/257) | 3.51 | 0.002319 | 0.036364 |
GO:0030061 | mitochondrial crista | 0.78% (2/257) | 4.79 | 0.002278 | 0.036571 |
GO:1990386 | mitotic cleavage furrow ingression | 0.78% (2/257) | 4.79 | 0.002278 | 0.036571 |
GO:0042144 | vacuole fusion, non-autophagic | 0.78% (2/257) | 4.79 | 0.002278 | 0.036571 |
GO:0010012 | steroid 22-alpha hydroxylase activity | 0.78% (2/257) | 4.79 | 0.002278 | 0.036571 |
GO:0031224 | intrinsic component of membrane | 14.79% (38/257) | 0.69 | 0.002343 | 0.036573 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 10.12% (26/257) | 0.87 | 0.002301 | 0.036594 |
GO:0110165 | cellular anatomical entity | 68.87% (177/257) | 0.19 | 0.002313 | 0.036609 |
GO:0048519 | negative regulation of biological process | 22.18% (57/257) | 0.53 | 0.002292 | 0.036633 |
GO:0030425 | dendrite | 2.33% (6/257) | 2.16 | 0.002401 | 0.036948 |
GO:0006810 | transport | 17.12% (44/257) | 0.63 | 0.002383 | 0.037023 |
GO:0031503 | protein-containing complex localization | 1.95% (5/257) | 2.44 | 0.002398 | 0.037074 |
GO:0016607 | nuclear speck | 3.11% (8/257) | 1.81 | 0.002275 | 0.037253 |
GO:0016071 | mRNA metabolic process | 5.84% (15/257) | 1.22 | 0.002266 | 0.037288 |
GO:0034399 | nuclear periphery | 1.17% (3/257) | 3.48 | 0.00249 | 0.037976 |
GO:0002090 | regulation of receptor internalization | 1.17% (3/257) | 3.48 | 0.00249 | 0.037976 |
GO:0006259 | DNA metabolic process | 6.23% (16/257) | 1.16 | 0.002526 | 0.038346 |
GO:0031974 | membrane-enclosed lumen | 5.45% (14/257) | 1.25 | 0.00264 | 0.039542 |
GO:0043233 | organelle lumen | 5.45% (14/257) | 1.25 | 0.00264 | 0.039542 |
GO:0070013 | intracellular organelle lumen | 5.45% (14/257) | 1.25 | 0.00264 | 0.039542 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 5.06% (13/257) | 1.31 | 0.002665 | 0.039736 |
GO:0045277 | respiratory chain complex IV | 0.78% (2/257) | 4.66 | 0.002721 | 0.039863 |
GO:0034377 | plasma lipoprotein particle assembly | 0.78% (2/257) | 4.66 | 0.002721 | 0.039863 |
GO:0034379 | very-low-density lipoprotein particle assembly | 0.78% (2/257) | 4.66 | 0.002721 | 0.039863 |
GO:0097576 | vacuole fusion | 0.78% (2/257) | 4.66 | 0.002721 | 0.039863 |
GO:0050789 | regulation of biological process | 42.02% (108/257) | 0.32 | 0.002746 | 0.040048 |
GO:0000122 | negative regulation of transcription by RNA polymerase II | 3.5% (9/257) | 1.63 | 0.002837 | 0.041202 |
GO:0006352 | DNA-templated transcription initiation | 1.56% (4/257) | 2.77 | 0.002878 | 0.041433 |
GO:0005798 | Golgi-associated vesicle | 1.56% (4/257) | 2.77 | 0.002878 | 0.041433 |
GO:0007549 | dosage compensation | 1.17% (3/257) | 3.37 | 0.003049 | 0.043337 |
GO:0071222 | cellular response to lipopolysaccharide | 1.17% (3/257) | 3.37 | 0.003049 | 0.043337 |
GO:0002064 | epithelial cell development | 1.17% (3/257) | 3.37 | 0.003049 | 0.043337 |
GO:0005488 | binding | 58.75% (151/257) | 0.23 | 0.003081 | 0.043605 |
GO:0030132 | clathrin coat of coated pit | 0.78% (2/257) | 4.55 | 0.003202 | 0.043831 |
GO:0007566 | embryo implantation | 0.78% (2/257) | 4.55 | 0.003202 | 0.043831 |
GO:0017158 | regulation of calcium ion-dependent exocytosis | 0.78% (2/257) | 4.55 | 0.003202 | 0.043831 |
GO:0008541 | proteasome regulatory particle, lid subcomplex | 0.78% (2/257) | 4.55 | 0.003202 | 0.043831 |
GO:0080132 | fatty acid alpha-hydroxylase activity | 0.78% (2/257) | 4.55 | 0.003202 | 0.043831 |
GO:0015937 | coenzyme A biosynthetic process | 0.78% (2/257) | 4.55 | 0.003202 | 0.043831 |
GO:0016070 | RNA metabolic process | 10.51% (27/257) | 0.82 | 0.003223 | 0.043933 |
GO:0017004 | cytochrome complex assembly | 1.17% (3/257) | 3.34 | 0.003251 | 0.044143 |
GO:1990904 | ribonucleoprotein complex | 6.23% (16/257) | 1.12 | 0.003149 | 0.044375 |
GO:0030133 | transport vesicle | 2.33% (6/257) | 2.08 | 0.003184 | 0.044677 |
GO:0051640 | organelle localization | 3.89% (10/257) | 1.49 | 0.003364 | 0.045306 |
GO:0032774 | RNA biosynthetic process | 3.11% (8/257) | 1.71 | 0.003358 | 0.045412 |
GO:0051354 | negative regulation of oxidoreductase activity | 1.17% (3/257) | 3.31 | 0.003461 | 0.046429 |
GO:0043226 | organelle | 48.64% (125/257) | 0.28 | 0.003523 | 0.046505 |
GO:0034641 | cellular nitrogen compound metabolic process | 19.84% (51/257) | 0.54 | 0.003542 | 0.046582 |
GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 10.12% (26/257) | 0.83 | 0.003517 | 0.046615 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 1.95% (5/257) | 2.31 | 0.003511 | 0.046726 |
GO:0048167 | regulation of synaptic plasticity | 1.56% (4/257) | 2.69 | 0.003504 | 0.046814 |
GO:0045071 | negative regulation of viral genome replication | 0.78% (2/257) | 4.44 | 0.00372 | 0.047058 |
GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen | 0.78% (2/257) | 4.44 | 0.00372 | 0.047058 |
GO:0002786 | regulation of antibacterial peptide production | 0.78% (2/257) | 4.44 | 0.00372 | 0.047058 |
GO:0018342 | protein prenylation | 0.78% (2/257) | 4.44 | 0.00372 | 0.047058 |
GO:0097354 | prenylation | 0.78% (2/257) | 4.44 | 0.00372 | 0.047058 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 7.78% (20/257) | 0.96 | 0.003764 | 0.047446 |
GO:0031327 | negative regulation of cellular biosynthetic process | 8.17% (21/257) | 0.94 | 0.003629 | 0.047529 |
GO:0005801 | cis-Golgi network | 1.17% (3/257) | 3.28 | 0.00368 | 0.047635 |
GO:1902410 | mitotic cytokinetic process | 1.17% (3/257) | 3.28 | 0.00368 | 0.047635 |
GO:0048262 | determination of dorsal/ventral asymmetry | 1.17% (3/257) | 3.28 | 0.00368 | 0.047635 |
GO:1902911 | protein kinase complex | 1.95% (5/257) | 2.29 | 0.003711 | 0.047856 |
GO:1990778 | protein localization to cell periphery | 2.33% (6/257) | 2.02 | 0.003885 | 0.048786 |
GO:0010216 | maintenance of DNA methylation | 1.17% (3/257) | 3.25 | 0.003906 | 0.048862 |
GO:0043228 | non-membrane-bounded organelle | 14.01% (36/257) | 0.67 | 0.003938 | 0.048898 |
GO:0043232 | intracellular non-membrane-bounded organelle | 14.01% (36/257) | 0.67 | 0.003938 | 0.048898 |